[go: up one dir, main page]

GB0103638D0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
GB0103638D0
GB0103638D0 GB0103638A GB0103638A GB0103638D0 GB 0103638 D0 GB0103638 D0 GB 0103638D0 GB 0103638 A GB0103638 A GB 0103638A GB 0103638 A GB0103638 A GB 0103638A GB 0103638 D0 GB0103638 D0 GB 0103638D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0103638A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GW Pharma Ltd
Original Assignee
GW Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GW Pharmaceuticals Ltd filed Critical GW Pharmaceuticals Ltd
Priority to GB0103638A priority Critical patent/GB0103638D0/en
Publication of GB0103638D0 publication Critical patent/GB0103638D0/en
Priority to US09/827,158 priority patent/US6730330B2/en
Priority to US09/951,022 priority patent/US7025992B2/en
Priority to CN02808220.6A priority patent/CN1886117B/en
Priority to NZ527289A priority patent/NZ527289A/en
Priority to GB0319041A priority patent/GB2388543A/en
Priority to EP02712063.3A priority patent/EP1361864B9/en
Priority to DE10296335T priority patent/DE10296335T5/en
Priority to SI200231042T priority patent/SI1361864T1/en
Priority to CA002438097A priority patent/CA2438097C/en
Priority to AU2002231970A priority patent/AU2002231970B2/en
Priority to PT2712063T priority patent/PT1361864E/en
Priority to EP10180638A priority patent/EP2298283A3/en
Priority to HK03108883.0A priority patent/HK1056509B/en
Priority to PCT/GB2002/000620 priority patent/WO2002064109A2/en
Priority to EP10180628.9A priority patent/EP2292211A3/en
Priority to CA2533400A priority patent/CA2533400C/en
Priority to EP10180665.1A priority patent/EP2298284A3/en
Priority to GB0203527A priority patent/GB2380129B/en
Priority to MXPA03007215A priority patent/MXPA03007215A/en
Priority to EP10180611.5A priority patent/EP2286793A3/en
Priority to PL364177A priority patent/PL216740B1/en
Priority to HU0303182A priority patent/HU227452B1/en
Priority to IL15713002A priority patent/IL157130A0/en
Priority to JP2002563905A priority patent/JP4467883B2/en
Priority to KR1020037010780A priority patent/KR100886668B1/en
Priority to US10/468,041 priority patent/US10004684B2/en
Priority to ES02712063.3T priority patent/ES2444641T3/en
Priority to DK02712063.3T priority patent/DK1361864T3/en
Priority to CZ2003-2458A priority patent/CZ306277B6/en
Priority to TW91102626A priority patent/TWI222882B/en
Priority to ZA2003/06074A priority patent/ZA200306074B/en
Priority to NO20033556A priority patent/NO334743B1/en
Priority to CY20141100157T priority patent/CY1115072T1/en
Priority to US15/586,478 priority patent/US20180042842A1/en
Ceased legal-status Critical Current

Links

GB0103638A 2001-02-14 2001-02-14 Pharmaceutical formulations Ceased GB0103638D0 (en)

Priority Applications (35)

Application Number Priority Date Filing Date Title
GB0103638A GB0103638D0 (en) 2001-02-14 2001-02-14 Pharmaceutical formulations
US09/827,158 US6730330B2 (en) 2001-02-14 2001-04-05 Pharmaceutical formulations
US09/951,022 US7025992B2 (en) 2001-02-14 2001-09-12 Pharmaceutical formulations
CZ2003-2458A CZ306277B6 (en) 2001-02-14 2002-02-14 Pump-action spray formulation
CA2533400A CA2533400C (en) 2001-02-14 2002-02-14 Cannabinoids pharmaceutical formulations
EP10180611.5A EP2286793A3 (en) 2001-02-14 2002-02-14 Pharmaceutical formulations comprising cannabidiol
GB0319041A GB2388543A (en) 2001-02-14 2002-02-14 Pharmaceutical formulations
EP02712063.3A EP1361864B9 (en) 2001-02-14 2002-02-14 Liquid spray formulations for buccal delivery of cannabinoids
DE10296335T DE10296335T5 (en) 2001-02-14 2002-02-14 Pharmaceutical formulations
SI200231042T SI1361864T1 (en) 2001-02-14 2002-02-14 Liquid spray formulations for buccal delivery of cannabinoids
CA002438097A CA2438097C (en) 2001-02-14 2002-02-14 Cannabinoids pharmaceutical formulations
AU2002231970A AU2002231970B2 (en) 2001-02-14 2002-02-14 Mucoadhesive pharmaceutical formulations
PT2712063T PT1361864E (en) 2001-02-14 2002-02-14 Liquid spray formulations for buccal delivery of cannabinoids
EP10180638A EP2298283A3 (en) 2001-02-14 2002-02-14 Pharmaceutical formulations comprising cannabinoids
HK03108883.0A HK1056509B (en) 2001-02-14 2002-02-14 Liquid spray formulations for buccal delivery of cannabinoids
PCT/GB2002/000620 WO2002064109A2 (en) 2001-02-14 2002-02-14 Mucoadhesive pharmaceutical formulations
EP10180628.9A EP2292211A3 (en) 2001-02-14 2002-02-14 Mucoadhesive pharmaceutical formulations
CN02808220.6A CN1886117B (en) 2001-02-14 2002-02-14 Pharmaceutical compositions
EP10180665.1A EP2298284A3 (en) 2001-02-14 2002-02-14 Mucoadhesive pharmaceutical formulations
GB0203527A GB2380129B (en) 2001-02-14 2002-02-14 Pharmaceutical formulations
MXPA03007215A MXPA03007215A (en) 2001-02-14 2002-02-14 Pharmaceutical formulations.
NZ527289A NZ527289A (en) 2001-02-14 2002-02-14 Lipophilic medicaments and their administration via mucosal surfaces
PL364177A PL216740B1 (en) 2001-02-14 2002-02-14 Mucoadhesive pharmaceutical formulations
HU0303182A HU227452B1 (en) 2001-02-14 2002-02-14 Mucoadhesive pharmaceutical formulation
IL15713002A IL157130A0 (en) 2001-02-14 2002-02-14 A cannabis based pharmaceutical formulation
JP2002563905A JP4467883B2 (en) 2001-02-14 2002-02-14 Pharmaceutical formulation
KR1020037010780A KR100886668B1 (en) 2001-02-14 2002-02-14 Pharmaceutical preparations
US10/468,041 US10004684B2 (en) 2001-02-14 2002-02-14 Pharmaceutical formulations
ES02712063.3T ES2444641T3 (en) 2001-02-14 2002-02-14 Liquid spray formulations for cannabinoid oral release
DK02712063.3T DK1361864T3 (en) 2001-02-14 2002-02-14 FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids
TW91102626A TWI222882B (en) 2001-02-14 2002-02-15 Pharmaceutical formulations
ZA2003/06074A ZA200306074B (en) 2001-02-14 2003-08-06 Mucoadhesive pharmaceutical formulations
NO20033556A NO334743B1 (en) 2001-02-14 2003-08-11 Pump-acting liquid spray formulation
CY20141100157T CY1115072T1 (en) 2001-02-14 2014-02-26 LIQUID COMPOSITIONS SPRAY FOR SUPPLY OF CANNIVOIDES THROUGH PARTY
US15/586,478 US20180042842A1 (en) 2001-02-14 2017-05-04 Pharmaceutical formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0103638A GB0103638D0 (en) 2001-02-14 2001-02-14 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
GB0103638D0 true GB0103638D0 (en) 2001-03-28

Family

ID=9908723

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0103638A Ceased GB0103638D0 (en) 2001-02-14 2001-02-14 Pharmaceutical formulations

Country Status (2)

Country Link
CN (1) CN1886117B (en)
GB (1) GB0103638D0 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI583374B (en) * 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 Use of plant cannabinoid cannabinol (CBDV) for the treatment of epilepsy
GB2495118B (en) * 2011-09-29 2016-05-18 Otsuka Pharma Co Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
WO2015065180A1 (en) * 2013-10-29 2015-05-07 Echo Pharmaceuticals B.V. Compressed tablet containing delta 9-tetrahydrocannabinol, method for its manufacture and use of such tablet in oral treatment
US11911361B2 (en) 2014-05-29 2024-02-27 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
NZ726746A (en) * 2014-05-29 2020-08-28 Fresh Cut Dev Llc Stable cannabinoid formulations
US11331279B2 (en) 2014-05-29 2022-05-17 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
CN107072980A (en) * 2014-08-22 2017-08-18 麦迪帕斯有限公司 What is used in medicine delivery is used for composition and the method that cannboid is coated
CA2993023C (en) * 2015-07-22 2020-04-28 Phytopharma International Ltd. Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby
CA3020616A1 (en) * 2016-04-12 2017-10-19 Habi Pharma Pty Ltd Liposomal preparation and methods of treatment
US20170348276A1 (en) * 2016-06-02 2017-12-07 Acerus Pharmaceutical Corporation Nasal cannabidiol compositions
CA3108112A1 (en) * 2018-07-18 2020-01-23 Glatt Gmbh Multiparticulate formulations of cannabinoids
CN110279678B (en) * 2019-06-15 2022-04-12 汉义生物科技（北京）有限公司 Cannabinoid-containing solid composition and preparation method and application thereof
CN110269840A (en) * 2019-06-15 2019-09-24 云南飞久逍科技有限公司 A kind of cannabidiol CBD nano-emulsion and preparation method thereof
CN111135144A (en) * 2020-01-22 2020-05-12 杭州诺莘科技有限责任公司 Pure natural high-stability cannabinoid nanoemulsion and preparation method thereof
CN113679682A (en) * 2020-05-19 2021-11-23 珠海润都制药股份有限公司 Nitroglycerin sublingual tablet and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560625A (en) * 1967-02-20 1971-02-02 Colgate Palmolive Co Method of,and formulations for,introducing alkoxybenzamides into the systemic circulatory system
ES2280343T3 (en) * 2000-03-09 2007-09-16 Gw Pharma Limited PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABIS.

Also Published As

Publication number Publication date
CN1886117A (en) 2006-12-27
CN1886117B (en) 2014-02-26

Similar Documents

Publication Publication Date Title
GB0319041D0 (en) Pharmaceutical Formulations
HUP0302857A3 (en) Pharmaceutical formulation
GB0210397D0 (en) Pharmaceutical formulations
GB0111597D0 (en) Pharmaceutical compositions
GB0118689D0 (en) Pharmaceutical formulation
GB0104534D0 (en) Pharmaceutical combination
PL366432A1 (en) Pharmaceutical formulation
GB0121715D0 (en) Pharmaceutical formulations
GB2380129B (en) Pharmaceutical formulations
GB0124523D0 (en) Pharmaceutical combination
GB0120701D0 (en) Pharmaceutical formulations
GB2392093B (en) Pharmaceutical formulations
GB0103638D0 (en) Pharmaceutical formulations
GB0105560D0 (en) Pharmaceutical formulations
IL161306A0 (en) Pharmaceutical formulation comprising (r)-bicalutamide
GB0104752D0 (en) Pharmaceutical compositions
GB0129270D0 (en) Pharmaceutical combination
GB0129397D0 (en) Pharmaceutical combination
GB2382302B (en) Pharmaceutical compositions
GB0124455D0 (en) Pharmaceutical formulations
GB0129395D0 (en) Pharmaceutical combination
GB0104749D0 (en) Pharmaceutical formulation
GB0115893D0 (en) Formulations
GB0118299D0 (en) Pharmaceutical formulations
GB0101966D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)